Fractyl Health, Inc. Common Stock
Fractyl Health, Inc. Common Stock (GUTS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
guts · stock forecast · 3 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 3 Wall Street analysts in the past 3 months
Buy
3 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$8.00
Consensus
$5.00
+646.3% upside
Low
$2.00
Median: $5 · Last Close: $0.67
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$5.00
646.3% upside
High Target
$8
1094.0%
Low Target
$2
198.5%
Current Price
$0.67
as of today
Based on analyst price targets, the GUTS stock price prediction for the next 12 months ranges from $2 to $8. The consensus GUTS price forecast of $5.00 implies 646.3% upside from the current price of $0.67.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.64 | ↓ 5.00% |
1-day model range: $0.63–$0.65. Peak: $0.65 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GUTS · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-26 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-01-30 | Morgan Stanley | Downgrade ↓ | Overweight→Equal Weight |
| 2025-12-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-21 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-09-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-14 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-02-03 | Morgan Stanley | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Fractyl Health, Inc. Common Stock (GUTS) stock. Of the recent 9 rating actions, 0 were upgrades and 1 were downgrades. 3 analysts currently cover GUTS.
Analyst Recommendation Trends
GUTS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$12M
↓ 86.5% YoY
Revenue Next Year
$22M
↑ 79.5% YoY
EPS This Year
$-0.37
EPS Next Year
$-0.53
↑ 43.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast GUTS EPS of $-0.37 for the current fiscal year, based on estimates from 4 analysts. The GUTS revenue forecast is $12M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The GUTS stock forecast is supported by two independent data sources: analyst consensus ratings from 3 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GUTS price target is $5.00 (+646.3% upside), with an analyst consensus of Buy.
The GUTS short-term stock prediction for tomorrow is $0.64 (-5.00%).
Fractyl Health, Inc. Common Stock trades on NASDAQ under the ticker GUTS. The GUTS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
GUTS forecast · 8 questionsAccording to 3 Wall Street analysts, the average 12-month GUTS price target is $5.00, with a high forecast of $8.00 and a low of $2.00. The median price target is shown in the chart above when available. This implies +646.3% potential upside from the current price of $0.67.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.